Infectious Disease Testing Instrumentation Market Size, Share, Statistics, Trend Analysis and Forecast Report, 2020 - 2027
Infectious Disease Testing Instrumentation Market Growth and Analysis
An increasing worldwide prevalence of infectious diseases, shift in focus from centralized laboratories to decentralized point-of-care testing, backed by growth in funding for research on infectious disease diagnostics are key factors generating high demand for infectious disease testing instrumentation. Enhanced accessibility and the increasing number of infectious disease diagnostic tests conducted globally add to the key drivers for this market. Advancements in sequencing technologies, increasing awareness, acceptance of personalized, and increasing application of molecular diagnostic technologies in pharmacogenetics are dynamic factors predicted to boost the growth of this technology in the future. The hospital-acquired infections segment are expected to record the highest CAGR in forthcoming years, because growth in this segment is triggered by the increasing burden of MRSA infections and increasing adoption of technologically advanced diagnostic tests such as Xpert MRSA NxG, BD MAX Cdiff assay and ARIES C. difficile assay based on PCR technology. Hepatitis diagnostics and HPV diagnostics markets are to witness booming growth because rapid HPV diagnostics and real-time PCR and proteomics are some of the most advanced methods which exhibit high levels of sensitivity to HPV and cover a wide range of genotypes. CT/NG infections. The increasing prevalence of CT/NG infections is another major factor fostering growth in the infectious disease testing instrumentation market. Further, the TB diagnostics market is mainly driven by increase of this disease across the globe, especially in developing and underdeveloped countries. Expansion in the influenza market triggered by the rising prevalence of influenza, increase in research funding for influenza diagnostics, and a rising demand for quicker and accurate diagnosis thereby ensuring control of influenza. By end user type, hospital and clinical laboratories segment is forecasted to record the highest CAGR in the future.
The market is experiencing slowdown for the pandemic situation, a short-term challenge affecting the pace of distribution.
Growth in this market is mainly driven by the global prevalence and outbreak of infectious diseases, shifting focus from centralized or organised laboratories to de-centralized point of care testing, and increased funding for research on infectious diseases diagnostics. Roche, Bio-Rad and bioMerieux are some of the major players of in the infectious diseases testing instrument market for kits, assays and reagents. Increased instances of strategic collaborations aiming at the enhancement of R&D for improved testing Instruments has created abundant growth opportunities in the market. With the outbreak of COVID 19 the Infectious Diseases Testing Instrument market has seen a whole new milestone and the necessity of investment in this field is being given serious thought by the governments and concerned authorities. North America accounts for the biggest share (44.0%) in the infectious diseases testing instrument market, the major share of this region is credited to the presence of highly developed healthcare system, presence of large numbers of leading clinical laboratories, and easy availability of technologically advanced instruments in the region. The Asia Pacific is projected to register the highest CAGR from 2019-2027, fueled by the presence of bigger investments and favourable government initiatives for infectious diseases testing, high unmet medical needs, the consequent increase in the disposable income, economic development in the emerging countries like China, India, South Korea etc
The global outbreak of coronavirus and the presence of infectious diseases such as Hepatitis, HIV, Influenza, and Tuberculosis is considerably high in spite of improvements and advancements in medicine and sanitation. Some of the currently available testing techniques and instruments are slow, involve complex procedures and lack precise identification of causative agents. This has lead to the emergence of super-resistant microbes. Also, faulty testing kits have been a problem in the testing market and are more prevalent with the outbreak of COVID 19. Growing awareness about the benefits of personalized medicine is the key factor resulting in increased use of diagnostic and genomics, molecular and proteomics technologies in infectious disease testing.
Infectious Disease Testing Instrumentation Market Regional Analysis
The Infectious Instrumentation Market is estimated to grow at the rate of 5.9 % of CAGR from 2018 to 12.88 billion dollars by 2025. North America is the largest market, followed by the European market. Also, Latin America and the Asia Pacific, mainly Japan, China, India, and Singapore are rapidly increasing in this market due to global awareness related to healthcare, increasing funding, rapid urbanization, etc. The companies which are contributing to the maximum proportion of the market include Danaher, Abbott Laboratories, Bio merieux SA, Quidel Corporation, Thermo Fisher Inc., Siemens Inc., Meridian Bioscience, Bio-Rad Laboratories, etc. Countries like Hong Kong, Macao, Japan, Singapore, Switzerland, Italy, Australia, Channel Islands, South Korea, Sweden, France, Israel, and Norway held an essential share in the industry due to the increased technology and healthcare facilities.
Infectious Disease Testing Instrumentation Market Competition
Key companies operating in this industry are Mindray, Autobio, Kpsontech, Roche Diagnostics, Beckman Coulter, Abbott, Siemens, Bio-Rad Laboratories, Becton Dickinson, Thermo Fischer Scientific, BioMerieux and Qiagen.
The testing products market is widely increasing in the regions of Asia Pacific and America. The companies are manufacturing new products and launching new techs to stay in the competitive business in the industry.
Indian companies are also leading in the industry producing new and effective diagnostic kits. J Mitra & Co., a leading company in providing diagnostic products, has launched a new test kit for the Covid-19 infected people ‘Total Antibody Detection Elisa Test Kit’, on 17 June 2020. Another leading firm in the industry, Celltrion Groups, has also contributed by launching a Point-of -Care Antigen Testing (POCT) Kit partnering with another diagnostic kits manufacturer, BBB, in June 2020. The companies have informed that their Testing kits are up to 95% sensitive.
• Infectious Disease Testing Instrumentation Market Revenue Estimation and Forecast (2020 – 2027)
• Production Estimation and Forecast (2020 – 2027)
• Sales/Consumption Volume Estimation and Forecast (2020 – 2027)
• Breakdown of Revenue by Segments (2020 – 2027)
• Breakdown of Production by Segments (2020 – 2027)
• Breakdown of Sales Volume by Segments (2020 – 2027)
• Gross Margin and Profitability Analysis of Companies
• Business Trend and Expansion Analysis
• Import and Export Analysis
Infectious Disease Testing Instrumentation Market Segmentation
Product Outlook (Revenue, USD Million, 2020 - 2027)
• Chemiluminescence Immunoassay
• Microplate Reader
Application Outlook (Revenue, USD Million, 2020 - 2027)
• Independent Testing Organization
Country (Revenue, USD Million, 2020 - 2027)
• United States
• United Kingdom
• South Korea
• Middle East
• Rest of World
Infectious Disease Testing Instrumentation Market Companies
• Roche Diagnostics
• Beckman Coulter
• Bio-Rad Laboratories
• Becton Dickinson
• Thermo Fischer Scientific
Please fill in the form below to Request for free Sample Report
Office Hours Mon - Sat 10:00 - 16:00
Send Us Mail email@example.com
© 2018 Market Decipher. All Rights Reserved